NASDAQ · PACB
Pacific Biosciences of California, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PACB: Nov 04, 2026
Pacific Biosciences of California, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.13. The reported EPS for the same quarter last year was $-0.12.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Dec 2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Mar 2027 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Jun 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · RTTNews- Zacks · Oct 29, 5:15 PM EDTPacific Biosciences of California (PACB) Rises As Market Takes a Dip: Key FactsIn the latest trading session, Pacific Biosciences of California (PACB) closed at $2.9, marking a +2.47% move from the previous day.
- Zacks · Oct 28, 6:30 PM EDTGlaukos (GKOS) Q3 Earnings and Revenues Surpass EstimatesGlaukos (GKOS) delivered earnings and revenue surprises of +491.67% and +24.99%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- BNK Invest · Oct 28, 12:17 PM EDTWednesday's ETF Movers: ARKG, EISIn trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 6.1% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 22.5% and shares of Prime Medicine, up about 19.3% on
- Zacks · Oct 27, 1:29 PM EDTHere's Why You Should Hold PacBio Stock in Your Portfolio for NowPACB's growing clinical adoption, advanced sequencing technologies and rising consumables sales support growth, but funding headwinds and margin pressures persist.
- RTTNews · Oct 23, 10:53 AM EDTWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win(RTTNews) – Healthcare and biotech news this week centred on regulatory approvals, strategic deals, and pivotal clinical data.
- Zacks · Oct 22, 5:15 PM EDTPacific Biosciences of California (PACB) Declines More Than Market: Some Information for InvestorsThe latest trading day saw Pacific Biosciences of California (PACB) settling at $2.06, representing a -3.74% change from its previous close.
- RTTNews · Oct 19, 10:09 AM EDTPacBio, Verily Health Partner To Build AI-Ready Genomic Datasets(RTTNews) – Pacific Biosciences of California, Inc. (PACB), a sequencing technologies developer and Verily Health Inc., a healthcare data intelligence company, announced a multi-year strategic collaboration to integrate PacBio HiFi sequencing with Verily Health's governed data an
- Zacks · Oct 13, 11:28 AM EDTPacBio Teams With TychoBio to Advance AI-Driven RNA TherapeuticsPACB partners with TychoBio to harness AI and long-read RNA sequencing for rare disease therapies, aiming to improve drug efficacy and safety through advanced data models.
- RTTNews · Oct 9, 1:37 PM EDTWeekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) – This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.
- Zacks · Oct 8, 5:15 PM EDTWhy Pacific Biosciences of California (PACB) Dipped More Than Broader Market TodayThe latest trading day saw Pacific Biosciences of California (PACB) settling at $2.3, representing a -15.44% change from its previous close.
- RTTNews · Oct 7, 7:25 AM EDTBiotech Stocks At 52-Week Highs – PACB, FTRE, ALMR, TXG, AZTA(RTTNews) – The following biotech stocks reached a 52-week high on October 6, 2026, driven by key catalysts such as newly announced research collaborations.
- RTTNews · Oct 6, 10:28 AM EDTPacBio And TychoBio Team Up On AI-Driven RNA Therapeutic Discovery(RTTNews) – Pacific Biosciences of California, Inc.(PACB) and TychoBio said they have entered into a collaboration to generate full-length RNA data that TychoBio will use to train AI models for RNA therapy design.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Pacific Biosciences of California, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.